Example
Example
Example
Example
Example
Example
Watch the videos
DACOPLICE® is a second-generation EGFR TKI
Start with proven first-line efficacy
First-line use of DACOPLICE® was studied in a Phase III, head-to-head trial with gefitinib
ARCHER 1050 study reported the most common adverse events in patients
DACOPLICE® is recommended by clinical practice guidelines
The Capital – A Wing, 1802, 18th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051, India.
® Trademark Proprietor – Pfizer Inc., USA, Licensed User – Pfizer Products India Private Limited, India
To view the summary of prescribing information for DACOPLICE®, please click here.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Full prescribing information available on request.
ARCHER, Adolescent Rural Cohort on Hormones, Education, Environment, Health and Relationships; EGFR, epidermal growth factor receptor; MoA, mechanism of action; NSCLC, non-small cell lung cancer; TKI, tyrosine kinase inhibitor.
References:
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.
Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.
Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.